Ausgabe 12/2013
Inhalt (9 Artikel)
Open Access
Letter from the Editor
Diabetes Treatment: Recent Developments
Aristidis Veves, Dimitrios Baltzis, Ioanna Eleftheriadou
Open Access
Letter from the Editor
“All I want for Christmas is Two”: The Advent of Novel Fixed-Combination Inhalers for COPD and Outlook for 2014
Kai M. Beeh
Review
Evolution of the Treatment Paradigm for Patients with Metastatic Castration-Resistant Prostate Cancer
Zafar Malik, Heather Payne, Jawaher Ansari, Simon Chowdhury, Mohammad Butt, Alison Birtle, Santhanam Sundar, Chinnamani Vee Eswar, Simon Hughes, Amit Bahl
Open Access
Review
The Dipeptidyl Peptidase (DPP)-4 Inhibitors for Type 2 Diabetes Mellitus in Challenging Patient Groups
David Kountz
Open Access
Original Research
The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension
Luis Ruilope, Angie Schaefer
Original Research
The Real-World Dose-Relativity of Sevelamer Hydrochloride and Lanthanum Carbonate Monotherapy in Patients with End-Stage Renal Disease
Rosamund J. Wilson, Michael S. Keith, Peter Preston, J. Brian Copley
Open Access
Original Research
Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration
Stephen S. Johnston, Kathleen Wilson, Alice Huang, David Smith, Helen Varker, Adam Turpcu
Open Access
Original Research
The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy
Sarah Thayer, Wenhui Wei, Erin Buysman, Lee Brekke, William Crown, Michael Grabner, Swetha Raparla, Ralph Quimbo, Mark J. Cziraky, Wenli Hu, Robert Cuddihy